Patents Assigned to Global Biodiagnostics Corp.
  • BETA LACTAMASE AS BIOMARKER FOR THE SPECIFIC DETECTION OF TUBERCULOSIS-COMPLEX BACTERIA
    Publication number: 20170350890
    Abstract: The present disclosure provides methods, reagents, systems, and devices that target ? lactamase as a biomarker for the sensitive and specific detection of tuberculosis-complex bacteria. Specifically, the present disclosure relates to methods and compositions for the detection of specific ?-lactamase protein and nucleic acid sequences to indicate the presence of tuberculosis-complex bacteria.
    Type: Application
    Filed: August 17, 2015
    Publication date: December 7, 2017
    Applicants: The Texas A&M University System, Global Biodiagnostics Corp.
    Inventors: Jeffrey D. Cirillo, Michael T. Norman